ロード中...
Therapeutic Outcome of Alemtuzumab in Korean Patients with Multiple Sclerosis: 2-Year Follow-Up
BACKGROUND AND PURPOSE: Alemtuzumab has shown high efficacy in clinical trials that primarily involved Western multiple sclerosis (MS) patients. To evaluate the therapeutic outcome of alemtuzumab in Korean patients with MS. METHODS: This study enrolled 23 consecutive patients who were treated with a...
保存先:
| 出版年: | J Clin Neurol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Neurological Association
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6620458/ https://ncbi.nlm.nih.gov/pubmed/31286704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2019.15.3.328 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|